Skip to main content
. 2005 Apr 13;64(10):1397–1405. doi: 10.1136/ard.2004.033332

Figure 6.

Figure 6

 The mean number of CD45RA, CD45RB, and CD45RO expressed as a percentage of CD3+cells. (A) Immunofluorescence double staining of peripheral blood mononuclear cells with CD3 plus CD45RA, CD45RB, or CD45RO in the five responders at screening and at 1, 3, 6, 9, and 12 months after HDC + ASCT. Results expressed as the percentage of CD3 cells expressing the CD45R isoform. (B) Immunofluorescence double staining of synovial cells with CD3 plus CD45RA, CD45RB, or CD45RO in the five responders at screening and 3 and 12 months after HDC + ASCT. Results expressed as the percentage of CD3 cells expressing the CD45R isoform.